Literature DB >> 1320557

Cutoff assignment strategies for enhancing randomized clinical trials.

W M Trochim1, J C Cappelleri.   

Abstract

The randomized clinical trial (RCT) is the preferred method for assessing the efficacy of treatments. Recent ethical and logistical criticisms suggest that new variations of the traditional RCT are needed. Some of these criticisms may be addressed with new hybrid designs that combine random assignment with assignment by one or more cutoff values on a baseline variable (e.g., severity of illness). In a simple version of such a "cutoff-based" RTC, persons scoring below a cutoff score on a baseline measure (i.e., the least severely ill) are automatically assigned to the control-treated group, those scoring above a second, higher cutoff (i.e., the most ill) are automatically assigned to the test-treated group, and those scoring in the interval between the cutoff scores (i.e., the moderately ill) are randomly assigned to either group. Depending on the baseline score, the patient is assigned to treatment either randomly or by the need-based, clinically related baseline score. Six cutoff-based design variations are studied via simulations and compared with the traditional RCT and the single-cutoff (i.e., regression-discontinuity) design. All variations yield unbiased estimates of the treatment effect but estimates differ in efficiency, with the RCT being most efficient and the single-cutoff design being least efficient. Secondary analyses of data from the Cross-National Collaborative Study of the Effects of Alprazolam (Xanax) on panic are conducted for each variation by selectivity discarding cases from the original dataset to stimulate cutoff-based assignment. The results confirm the simulations and illustrate how cutoff-based designs might look with real data.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1320557     DOI: 10.1016/0197-2456(92)90003-i

Source DB:  PubMed          Journal:  Control Clin Trials        ISSN: 0197-2456


  5 in total

Review 1.  Designing studies that would address the multilayered nature of health care.

Authors:  David M Murray; Michael Pennell; Dale Rhoda; Erinn M Hade; Electra D Paskett
Journal:  J Natl Cancer Inst Monogr       Date:  2010

2.  Application of regression-discontinuity analysis in pharmaceutical health services research.

Authors:  Ilene H Zuckerman; Euni Lee; Anthony K Wutoh; Zhenyi Xue; Bruce Stuart
Journal:  Health Serv Res       Date:  2006-04       Impact factor: 3.402

3.  Neural function, injury, and stroke subtype predict treatment gains after stroke.

Authors:  Erin Burke Quinlan; Lucy Dodakian; Jill See; Alison McKenzie; Vu Le; Mike Wojnowicz; Babak Shahbaba; Steven C Cramer
Journal:  Ann Neurol       Date:  2014-12-04       Impact factor: 10.422

4.  Cutoff designs for community-based intervention studies.

Authors:  Michael L Pennell; Erinn M Hade; David M Murray; Dale A Rhoda
Journal:  Stat Med       Date:  2011-04-17       Impact factor: 2.373

5.  Informed consent and research design in critical care medicine.

Authors: 
Journal:  Crit Care       Date:  1999       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.